Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:natural killer cell lymphoblastic leukemia/lymphoma'
(id=7111796 ; fe=en:natural killer cell lymphoblastic leukemia/lymphoma ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2024 creation date=2017-06-25 touchdate=2025-12-08 21:11:36.000)
≈ 48 relations sortantes

  1. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 35 / 1 -> en:atypical lymphocyte observed
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:atypical lymphocyte observed | rel=r_associated | relid=0 | w=35
  2. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 35 / 1 -> en:hematopoietic and lymphoid tissue
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:hematopoietic and lymphoid tissue | rel=r_associated | relid=0 | w=35
  3. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 35 / 1 -> en:neoplastic lymphocyte
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:neoplastic lymphocyte | rel=r_associated | relid=0 | w=35
  4. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 32 / 0.914 -> en:neoplastic cell
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=32
  5. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 32 / 0.914 -> en:neoplastic lymphoblast
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:neoplastic lymphoblast | rel=r_associated | relid=0 | w=32
  6. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 31 / 0.886 -> en:hematopoietic and lymphoid cell
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:hematopoietic and lymphoid cell | rel=r_associated | relid=0 | w=31
  7. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 30 / 0.857 -> en:b lymphoblastic leukemia/lymphoma
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:b lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=30
  8. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 30 / 0.857 -> en:blasts expressing b-lymphoid and myeloid markers present
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:blasts expressing b-lymphoid and myeloid markers present | rel=r_associated | relid=0 | w=30
  9. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:acute lymphoblastic leukemia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=29
  10. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:bone marrow
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:bone marrow | rel=r_associated | relid=0 | w=29
  11. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:lymphatic system
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:lymphatic system | rel=r_associated | relid=0 | w=29
  12. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:lymphoid tissue
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:lymphoid tissue | rel=r_associated | relid=0 | w=29
  13. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:malignant cell
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:malignant cell | rel=r_associated | relid=0 | w=29
  14. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 29 / 0.829 -> en:t lymphoblastic leukemia/lymphoma
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=29
  15. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 28 / 0.8 -> en:clonal t-cell receptor gamma chain gene rearrangement
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:clonal t-cell receptor gamma chain gene rearrangement | rel=r_associated | relid=0 | w=28
  16. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 28 / 0.8 -> en:cutaneous precursor lymphoid neoplasm
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:cutaneous precursor lymphoid neoplasm | rel=r_associated | relid=0 | w=28
  17. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 27 / 0.771 -> en:clonal antigen receptor gene rearrangement
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:clonal antigen receptor gene rearrangement | rel=r_associated | relid=0 | w=27
  18. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 27 / 0.771 -> en:clonal t-cell receptor beta chain gene rearrangement
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:clonal t-cell receptor beta chain gene rearrangement | rel=r_associated | relid=0 | w=27
  19. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 27 / 0.771 -> en:lymphocyte
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:lymphocyte | rel=r_associated | relid=0 | w=27
  20. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 27 / 0.771 -> en:neoplastic hematopoietic and lymphoid cell
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:neoplastic hematopoietic and lymphoid cell | rel=r_associated | relid=0 | w=27
  21. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:benign cellular infiltrate
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:benign cellular infiltrate | rel=r_associated | relid=0 | w=26
  22. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:blasts of mixed phenotype present
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:blasts of mixed phenotype present | rel=r_associated | relid=0 | w=26
  23. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:hematopoietic and lymphatic system
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:hematopoietic and lymphatic system | rel=r_associated | relid=0 | w=26
  24. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:lymphoblast
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:lymphoblast | rel=r_associated | relid=0 | w=26
  25. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:myeloid cells
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:myeloid cells | rel=r_associated | relid=0 | w=26
  26. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> en:precursor cell lymphoblastic lymphoma
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:precursor cell lymphoblastic lymphoma | rel=r_associated | relid=0 | w=26
  27. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 26 / 0.743 -> leucémie
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=leucémie | rel=r_associated | relid=0 | w=26
  28. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 25 / 0.714 -> cellule
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=cellule | rel=r_associated | relid=0 | w=25
  29. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 25 / 0.714 -> en:natural
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:natural | rel=r_associated | relid=0 | w=25
  30. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 23 / 0.657 -> cellule tumorale
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=cellule tumorale | rel=r_associated | relid=0 | w=23
  31. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:acute undifferentiated leukemia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:acute undifferentiated leukemia | rel=r_associated | relid=0 | w=20
  32. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:blasts expressing cd56 and immature t-cell markers present
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:blasts expressing cd56 and immature t-cell markers present | rel=r_associated | relid=0 | w=20
  33. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:bone medulla
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:bone medulla | rel=r_associated | relid=0 | w=20
  34. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:granulocytopenia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:granulocytopenia | rel=r_associated | relid=0 | w=20
  35. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:medulla ossium
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:medulla ossium | rel=r_associated | relid=0 | w=20
  36. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:mixed phenotype acute leukemia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:mixed phenotype acute leukemia | rel=r_associated | relid=0 | w=20
  37. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:solid growth pattern
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:solid growth pattern | rel=r_associated | relid=0 | w=20
  38. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:thrombocytopenia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=20
  39. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:thrombopenia
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:thrombopenia | rel=r_associated | relid=0 | w=20
  40. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:thrombopeny
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:thrombopeny | rel=r_associated | relid=0 | w=20
  41. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:tumor cell
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:tumor cell | rel=r_associated | relid=0 | w=20
  42. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> en:unfavorable clinical outcome
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:unfavorable clinical outcome | rel=r_associated | relid=0 | w=20
  43. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> moelle osseuse
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=moelle osseuse | rel=r_associated | relid=0 | w=20
  44. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> moëlle osseuse
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=moëlle osseuse | rel=r_associated | relid=0 | w=20
  45. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> Moelle osseuse
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=Moelle osseuse | rel=r_associated | relid=0 | w=20
  46. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> thrombocytopénie
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=thrombocytopénie | rel=r_associated | relid=0 | w=20
  47. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 20 / 0.571 -> thrombopénie
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=thrombopénie | rel=r_associated | relid=0 | w=20
  48. en:natural killer cell lymphoblastic leukemia/lymphoma -- r_associated #0: 1 / 0.029 -> en:neoplastic process
    n1=en:natural killer cell lymphoblastic leukemia/lymphoma | n2=en:neoplastic process | rel=r_associated | relid=0 | w=1
≈ 55 relations entrantes

  1. cellule tumorale --- r_associated #0: 165 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=cellule tumorale | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=165
  2. en:neoplastic cell --- r_associated #0: 162 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:neoplastic cell | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=162
  3. moëlle osseuse --- r_associated #0: 90 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=moëlle osseuse | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=90
  4. en:bone marrow --- r_associated #0: 87 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:bone marrow | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=87
  5. en:tumor cell --- r_associated #0: 78 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:tumor cell | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=78
  6. moelle osseuse --- r_associated #0: 60 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=moelle osseuse | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=60
  7. Moelle osseuse --- r_associated #0: 50 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=Moelle osseuse | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=50
  8. en:thrombocytopenia --- r_associated #0: 50 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:thrombocytopenia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=50
  9. thrombocytopénie --- r_associated #0: 46 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=thrombocytopénie | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=46
  10. en:bone medulla --- r_associated #0: 38 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:bone medulla | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=38
  11. en:medulla ossium --- r_associated #0: 37 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:medulla ossium | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=37
  12. en:acute undifferentiated leukemia --- r_associated #0: 35 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:acute undifferentiated leukemia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=35
  13. en:unfavorable clinical outcome --- r_associated #0: 35 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:unfavorable clinical outcome | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=35
  14. en:hematopoietic and lymphoid tissue --- r_associated #0: 34 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:hematopoietic and lymphoid tissue | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=34
  15. en:solid growth pattern --- r_associated #0: 34 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:solid growth pattern | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=34
  16. thrombopénie --- r_associated #0: 34 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=thrombopénie | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=34
  17. en:blasts expressing cd56 and immature t-cell markers present --- r_associated #0: 32 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:blasts expressing cd56 and immature t-cell markers present | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=32
  18. en:blasts expressing b-lymphoid and myeloid markers present --- r_associated #0: 31 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:blasts expressing b-lymphoid and myeloid markers present | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=31
  19. en:mixed phenotype acute leukemia --- r_associated #0: 31 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:mixed phenotype acute leukemia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=31
  20. en:neoplastic hematopoietic and lymphoid cell --- r_associated #0: 30 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:neoplastic hematopoietic and lymphoid cell | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=30
  21. en:clonal antigen receptor gene rearrangement --- r_associated #0: 28 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:clonal antigen receptor gene rearrangement | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=28
  22. en:hematopoietic and lymphoid cell --- r_associated #0: 28 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:hematopoietic and lymphoid cell | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=28
  23. en:thrombopenia --- r_associated #0: 28 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:thrombopenia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=28
  24. en:thrombopeny --- r_associated #0: 28 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:thrombopeny | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=28
  25. en:granulocytopenia --- r_associated #0: 26 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:granulocytopenia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=26
  26. en:medullary substance of bones --- r_associated #0: 23 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:medullary substance of bones | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=23
  27. Thrombopénie --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=Thrombopénie | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  28. en:acute lymphoblastic leukemia --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:acute lymphoblastic leukemia | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  29. en:atypical lymphocyte observed --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:atypical lymphocyte observed | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  30. en:b lymphoblastic leukemia/lymphoma --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:b lymphoblastic leukemia/lymphoma | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  31. en:benign cellular infiltrate --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:benign cellular infiltrate | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  32. en:blasts of mixed phenotype present --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:blasts of mixed phenotype present | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  33. en:clonal t-cell receptor beta chain gene rearrangement --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:clonal t-cell receptor beta chain gene rearrangement | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  34. en:clonal t-cell receptor gamma chain gene rearrangement --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:clonal t-cell receptor gamma chain gene rearrangement | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  35. en:cutaneous precursor lymphoid neoplasm --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:cutaneous precursor lymphoid neoplasm | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  36. en:hematopoietic and lymphatic system --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:hematopoietic and lymphatic system | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  37. en:lymphatic system --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:lymphatic system | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  38. en:lymphoblast --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:lymphoblast | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  39. en:lymphocyte --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:lymphocyte | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  40. en:lymphoid tissue --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:lymphoid tissue | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  41. en:malignant cell --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:malignant cell | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  42. en:myeloid cells --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:myeloid cells | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  43. en:neoplastic lymphoblast --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:neoplastic lymphoblast | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  44. en:neoplastic lymphocyte --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:neoplastic lymphocyte | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  45. en:precursor cell lymphoblastic lymphoma --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:precursor cell lymphoblastic lymphoma | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  46. en:t lymphoblastic leukemia/lymphoma --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=en:t lymphoblastic leukemia/lymphoma | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  47. leucémie --- r_associated #0: 20 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=leucémie | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=20
  48. Moëlle osseuse --- r_associated #0: 15 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=Moëlle osseuse | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=15
  49. Thrombocytopénie --- r_associated #0: 10 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=Thrombocytopénie | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=10
  50. lymphocyte --- r_associated #0: 10 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=lymphocyte | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=10
  51. moelle épinière (traumatisme de la) --- r_associated #0: 10 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=moelle épinière (traumatisme de la) | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=10
  52. système lymphatique --- r_associated #0: 10 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=système lymphatique | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=10
  53. thrombolytique (traitement) --- r_associated #0: 10 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=thrombolytique (traitement) | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=10
  54. lymphocyte atypique observé --- r_associated #0: 5 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=lymphocyte atypique observé | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=5
  55. lymphocyte néoplasique --- r_associated #0: 5 --> en:natural killer cell lymphoblastic leukemia/lymphoma
    n1=lymphocyte néoplasique | n2=en:natural killer cell lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr